Dr. Bing Hu

Associate Professor
Shanghai University of Traditional Chinese Medicine, China

Highest Degree
Ph.D. in Oncology from Sichuan University, Chengdu, China

My URL
https://livedna.org/86.10897

Share this Profile

Biography

Dr. Bing Hu is currently working as Associate Professor at Longhua Hospital, China. He has completed his Ph.D. in Oncology from Sichuan University, Chengdu, China, and Postdoctoral Fellow in Cancer, Functional, Genomics and Cancer Immunology, Shanghai Jiao Tong University, Shanghai, P. R. China. Previously he was appointed as Research Assistant at Shanghai Huaguan Biochip Co., Ltd., Shanghai, P. R. China. Oncologist-in-Charge at Department of Oncology, The First People’s Hospital of Chenzhou, Chenzhou, P. R. China, and Resident Physician at Yunyang Hospital of Traditional Chinese Medicine, Chongqing, P. R. China. Dr. Bing received honors include The 5th Integrative Medicine Award of Shanghai Municipality, The 25th Excellent Invention Award of Shanghai Municipality Silver Snake Award of Shanghai Municipality The 13th Ben-Ze-Bao-Zu Award of Longhua Hospital, and Outstanding Paper Award from Journal of Clinical Rehabilitative Tissue Engineering Research. He has published 71 research articles in journals contributed as author/co-author. He is also serving as member of editorial board and reviewer for journals such as China Journal of Experimental Traditional Medical Formulae, World Journal of Integrated Traditional and Western Medicine, International Journal of Integrative Medicine, International Journal of Pharmacy and Pharmaceutical Sciences, BMC Complementary and Alternative Medicine, Evidence-Based Complementary and Alternative Medicine, Cancer Biotherapy and Radiopharmaceuticals and many others. He is professional member of Chinese Medical Association, China Association of Chinese Medicine, Chinese Medical Doctor Association, World Federation of Chinese Medicine Societies, and Shanghai Association of Chinese Medicine.

Area of Interest:

Biomedical Sciences
Pathogenesis
Oncology
Cancer
Hepatocarcinoma

Selected Publications

  1. Wei, M.M., B. Hu and K.P. Shen, 2014. The therapeutic and preventive effects of Chinese herb against colorectal cancer. China J. Trad. Chinese Med. Pharm., 29: 2556-2559.

  2. Hu, B., Q. Du, S. Deng, H.M. An and C.F. Pan et al., 2014. Ligustrum lucidum Ait. fruit extract induces apoptosis and cell senescence in human hepatocellular carcinoma cells through upregulation of p21. Oncol. Rep., 32: 1037-1042.
    CrossRef  |  Direct Link  |  

  3. An, H.M., G.W. Li, C. Lin, C. Gu and M. Jin et al., 2014. Acorus tatarinowii Schott extract protects PC12 cells from amyloidinduced neurotoxicity. Die Pharmazie-Int. J. Pharm. Sci., 69: 391-395.
    CrossRef  |  Direct Link  |  

  4. Hu, B., K.P. Shen, X.F. Shi, S. Deng and M.M. Wei, 2013. Experimental research of RKO cell anoikis induced by Duchesnea indica in human colon cancer. World J. Integr. Trad. West Med., 8: 69-72.
    Direct Link  |  

  5. Du, Q., B. Hu, H.M. An, K.P. Shen, L. Xu, S. Deng and M.M. Wei, 2013. Synergistic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells. Oncol. Rep., 29: 1851-1858.
    CrossRef  |  Direct Link  |  

  6. Deng, S., B. Hu, H.M. An, Q. Du and L. Xu et al., 2013. Teng-Long-Bu-Zhong-Tang, a Chinese herbal formula, enhances anticancer effects of 5-Fluorouracil in CT26 colon carcinoma. BMC Complement. Alternat. Med., Vol. 13. 10.1186/1472-6882-13-128.
    CrossRef  |  Direct Link  |  

  7. An, H.M., Y.F. Xue, Y.L. Shen, Q. Du and B. Hu, 2013. Sodium valproate induces cell senescence in human hepatocarcinoma cells. Molecules, 18: 14935-14947.

  8. Shen, K.P., H.Y. Wng and B. Hu, 2012. Antitumor effect of Wei-Chang-an decoction on subcutaneously implanted human gastric cancer in nude mice. Liaoning J. Trad. Chin. Med., 39: 215-217.

  9. Shen, K.P., H.Y. Wang and B. Hu, 2012. Effects of Wei-Chang-an on the expression of epithelial mesenchymal transition related genes in SGC-7901 gastric carcinoma. Lishizhen Med. Mater. Med. Res., 23: 846-847.

  10. Hu, B., Q. Du, K.P. Shen and L. Xu, 2012. Principles and scientific basis of traditional Chinese medicine in cancer treatment. J. Bioanal. Biomed., Vol. 6. 10.4172/1948-593X.S6-005.
    CrossRef  |  Direct Link  |  

  11. Hu, B., H.M. An, K.P. Shen, L. Xu, Q. Du, S. Deng and Y. Wu, 2012. Liver Yin deficiency tonifying herbal extract induces apoptosis and cell senescence in Bel-7402 human hepatocarcinoma cells. Exp. Therapeut. Med., 3: 80-86.
    CrossRef  |  Direct Link  |  

  12. Hu, B., H.M. An, K.P. Shen, H.Y. Song and S. Deng, 2012. Polygonum cuspidatum extract induces anoikis in hepatocarcinoma cells associated with generation of reactive oxygen species and downregulation of focal adhesion kinase. Evid.-Based Complement. Alternat. Med., Vol. 2012. 10.1155/2012/607675.
    CrossRef  |  Direct Link  |  

  13. He, P., K.P. Shen and B. Hu, 2012. Progress in treatment of traditional Chinese medicine for gastric cancer. Chin. Arch. Trad. Chin. Med., 30: 280-282.

  14. Du, Q., K.P. Shen, B. Hu and S. Deng, 2012. [Effects of resveratrol on apoptosis and ROS production in Hepa 1-6 hepatocarcinoma cells]. J. Chinese Med. Mater., 35: 443-448, (In Chinese).
    PubMed  |  

  15. Deng, S., B. Hu, K.P. Shen and L. Xu, 2012. Inflammation, macrophage in cancer progression and Chinese herbal treatment. J. Basic Clin. Pharm., 3: 269-272.
    Direct Link  |  

  16. Deng, S., B. Hu and K. Shen, 2012. Pathogenesis and treatment of colorectal cancer in traditional Chinese medicine. World Sci. Tech. Modernizaztion Tradit. Chin. Med. Mater. Med., 14: 1858-1862.

  17. Deng, S., B. Hu and H.M. An, 2012. Traditional Chinese medicinal syndromes and treatment in colorectal cancer. J. Cancer Therapy, 3: 888-897.
    CrossRef  |  Direct Link  |  

  18. An, H.M., B. Hu, S.L. Xing, Z.H. Yu, J.L. Chen and M. Jin, 2012. Effect of Dihuang Yizhi Fang on cell cycle related gene expression in senile dementia rats induced by Aβ1-40. Chin. J. Informn. Trad. Chin. Med., 19: 47-49.
    Direct Link  |  

  19. An, H.M., B. Hu, J.L. Chen, Z.H. Yu, M. Jin, C. Gu and S. Xing, 2012. Effects of Dihuang Yizhifang on apoptosis related gene expression in senile dementia rats induced by Aβ1-40. Pharm. Clin. Chin. Mater. Med., 28: 141-144.
    Direct Link  |  

  20. Wang, H.Y., K.P. Shen and B. Hu, 2011. in anti-metastasis research of traditional Chinese medicine in gastric cancer. Chin. Arch. Trad. Chin. Med., 29: 1026-1028.

  21. Wang, H.Y., K.P. Shen and B. Hu, 2011. The effects of Wei-Chang-An on p-AKT and Twist proteins in SGC-7901 gastric carcinoma. China J. Chin. Med., 26: 1409-1411.

  22. Shen, K.P., H.Y. Wang and B. Hu, 2011. Epithelial-mesenchymal transition and anti-metastasis effects of traditional Chinese medicine. World J. Integr. Trad. West Med., 6: 87-89.

  23. Shen, K.P., H.Y. Wang and B. Hu, 2011. Effects of Weichangan decoction on TGFβ1 induced epithelial mesenchymal transition in gastric carcinoma SGC-7901 cells. J. Exp. Trad. Med. Formulae, 17: 132-135.

  24. Shen, K.P., B. Hu and W. Liu, 2011. Effects of siteng fang on proliferation and apoptosis in bel-7402 cells in vitro. Chin. J. Exp. Trad. Med. Formulae, 17: 120-123.
    Direct Link  |  

  25. Liu, W., K.P. Shen and B. Hu, 2011. Effects of Xialongfang on adhesion and migration in SGC-7901 gastric carcinoma cells. J. Exp. Trad. Med. Formulae, 17: 192-195.

  26. Hu, B., K.P. Shen, H.M. An, Y. Wu and Q. Du, 2011. Aqueous extract of Curcuma aromatica induces apoptosis and G2/M arrest in human colon carcinoma LS-174-T cells independent of p53. Cancer Biotherapy Radiopharmaceut., 26: 97-104.
    CrossRef  |  Direct Link  |  

  27. Hu, B., H.M. An, K.P. Shen, L. Xu, Q. Du, S. Deng and Y. Wu, 2011. Modified Yi Guan Jian, a Chinese herbal formula, induces anoikis in Bel-7402 human hepatocarcinoma cells in vitro. Oncol. Rep., 26: 1465-1470.
    CrossRef  |  Direct Link  |  

  28. Du, Q., S. Deng, K.P. Shen and B. Hu, 2011. Effects of curcumin on ROS production and apoptosis in murine hepatocarcinoma Hepa 1-6 cells. Pharm. Clin. Chin. Mater. Med., 27: 28-31.
    Direct Link  |  

  29. Shen, K.P., B. Hu and H.Y. Xue, 2010. Huangqi injection with IL-2 improve immune function of gastric cancer patients. Liaoning J. Trad. Chin. Med., 37: 1733-1735.

  30. Liu, W., K.P. Shen and B. Hu, 2010. The effects of Si-teng-fang on anoikis in gastric carcinoma SGC-7901 cells. World J. Integr. Trad. West Med., 12: 1025-1028.

  31. Liu, W., K.P. Shen and B. Hu, 2010. Effects of Sitengfang on adhesion and migration in SGC-7901 gastric carcinoma cells. World Chin. J. Digest, 18: 3616-3620.

  32. Liu, W., K.P. Shen and B. Hu, 2010. Anoikis and anti-cancer effects of Chinese herbs. China J. Trad. Chin. Med. Pharm., 12: 2058-2060.

  33. Hu, B., H.M. An, K.P. Shen and Q. Du, 2010. [Senescence-inducing effects of Chinese herbal medicine Tenglong Buzhong Decoction on human colon carcinoma LS-174-T cells and the mechanism]. J. Chin. Integrat. Med., 8: 1048-1052, (In Chinese).
    PubMed  |  

  34. Hu, B., H.M. An, K.P. Shen and Q. Du, 2010. [Effects of Tenglong Buzhong decoction on proliferation and apoptosis of human colon carcinoma cell line LS174T]. J. Chin. Integrat. Med., 8: 575-580, (In Chinese).
    PubMed  |  

  35. Du, Q., B. Hu and K.P. Shen, 2010. Traditional Chinese medicinal pathogenesis and therapeutic methods in hepatocarcinoma. World J. Integr. Trad. West Med., 5: 814-817.

  36. Du, Q., B. Hu and K.P. Shen, 2010. Compatibility of Chinese anti-cancer herb. Chin. J. Exp. Trad. Med. Formulae, 16: 232-235.
    Direct Link  |  

  37. Du, Q., B. Hu and K.P. Shen, 2010. Anti-cancer effects of tonic Chinese herbs in hepatocarcinoma. J. Chin. Med. Mater., 33: 1512-1516.

  38. Hu, B., H.M. An and K.P. Shen, 2009. Syndrome differential anti-cancer and scientific anti-cancer. Chin. J. Ethnomed. Ethnopharm., 18: 33-34.

  39. Hu, B., H.M. An and K.P. Shen, 2009. Low dose of etoposide induces cell senescence in colon carcinoma. Tumor, 29: 711-714.

  40. Hu, B., H.M. An and K.P. Shen, 2009. Liver and kidney yin-deficiency and hepatocarcinogenesis. Chin. J. Inform. Trad. Chin. Med., 16: 93-93.

  41. Hu, B., K.P. Shen and H.M. An, 2008. Cell senescence, cancer treatment and kidney theory of traditional Chinese medicine. Chin. J. Inform. Trad. Chin. Med., 15: 8-9.

  42. Hu, B., H.M. An and K.P. Shen, 2008. [Pharmacological study of Buzhong Yiqi decoction: A review]. J. Chin. Integrat. Med., 6: 752-755, (In Chinese).
    PubMed  |  

  43. Hu, B., H.M. An and K.P. Shen, 2008. Kidney theory of traditional Chinese medicine and stem cell research. J. Clin. Rehabil. Tissue Eng. Res., 12: 598-600.
    Direct Link  |  

  44. Hu, B., H.M. An and K.P. Shen, 2008. Cellular senescence and carcinogenesis. Chin. Bull. Life Sci., 20: 447-449.

  45. Hu, B. and K.P. Shen, 2008. Anti-cancer effects and mechanism of Astragalus membranaceus. J. Chin. Med. Mater., 31: 461-465.

  46. An, H.M., B. Hu, Y.F. Shi, Z.P. Zhang and L.W. Xu et al., 2008. Effects of nourishing kidney-yang on the activities of embryonic stem cell and related gene expression. China J. Trad. Chin. Med. Pharm., 23: 774-776.
    Direct Link  |  

  47. Shi, Y.F., B. Hu and H.M. An, 2007. Study of cell senescnece and traditional Chinese medicine. J. Shaanxi Coll. Trad. Chin. Med., 30: 62-64.

  48. Shi, Y.F., B. Hu and H.M. An, 2007. Research progress of stem cell in traditional Chinese medicine. Shanghai J. Trad. Chin. Med., 41: 78-80.

  49. Hu, B., Y.Q. Wei, L. Tian, X. Zhao and Y. Lu et al., 2006. Human T lymphocyte responses against lung cancer induced by recombinant truncated mouse EGFR. Cancer Immunol. Immunother., 55: 386-393.
    CrossRef  |  Direct Link  |  

  50. An, H.M. and B. Hu, 2006. Based on embryonic stem cell to explore the traditional Chinese medicine theory of kidney being congenital origin. Chin. J. Inform. Trad. Chin. Med., 13: 89-91.

  51. Wu, Y., L. Yang, B. Hu, J.Y. Liu and J.M. Su et al., 2005. Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine. Anti-Cancer Drugs, 16: 551-557.
    Direct Link  |  

  52. Hu, B., Y. Wei, L. Tian, X. Zhao and Y. Lu et al., 2005. Active antitumor immunity elicited by vaccine based on recombinant form of epidermal growth factor receptor. J. Immunother., 28: 236-244.
    Direct Link  |  

  53. Hu, B. and Y.Q. Wei, 2005. Receptor selection and B cell immune tolerance. J. Biomed. Eng., 22: 374-376.

  54. Hu, B. and Y.Q. Wei, 2004. Molecular mimicry associated with infection, autoimmunity and tumor immunotherapy. Chin. Bull. Life Sci., 16: 66-72.

  55. Hu, B. and Y.Q. Wei, 2004. Cancer biotherapy based on epidermal growth factor receptor as a target. Chin. J. Cancer, 23: 471-475.

  56. An, H.M. and B. Hu, 2004. Novel approach for exploring kidney-deficiency resulted senescence. Chin. J. Basic Med. Trad. Chin. Med., 10: 42-44.

  57. Hu, B., L. Tian, Y. Lu, L. Yang, X. Zhao, J. Liu and Y. Wei, 2003. [Expression, purification and refolding of extracellular domain of mouse epidermal growth factor receptor]. J. Biomed. Eng., 20: 264-267, (In Chinese)..
    PubMed  |  

  58. Hu, B. and Y. Wei, 2003. T cell homeostatic proliferation associated with autoimmunity and antitumor immunity. J. Immunol., 20: 239-241.
    PubMed  |  

  59. Hu, B., L. Tian, J. Liu, Y. Lu, X. Zhao and Y. Wei, 2002. Prokaryotic expression of extracellular domain of human EGFR and it's immunogenity. West China Med. J., 18: 5-6.
    PubMed  |  
Member since February, 2016